Wendel Naumann

5PUBLICATIONS
25CO-AUTHORS
Molecular targetsFine artsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

|May 24, 2024
The SHAPE trial: is good is good enough?

R Wendel Naumann

|Feb 22, 2023
Opioid and benzodiazepine use in gynecologic oncology patients.

Khrystyna Levytska, Savannah R Pena, Jubilee Brown

|Jul 15, 2022
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.

Carol J Farhangfar, Gregory T Scarola, Victoria A Morris

|Apr 19, 2022
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.

Siqing Fu, Bradley R Corr, Kerry Culm-Merdek

Pageof 1

Frequent Collaborators

1 joint publications

Siqing Fu

1 joint publications

Robert M Wenham

1 joint publications

Rafael D Rosengarten

1 joint publications

Erika Paige Hamilton